Remdesivir Tied To Several Hepatobiliary ADRs, Study Finds

June 24, 2021

Gastroenterology Advisor (6/23, Soreca) reports treatment with remdesivir “was associated with several hepatobiliary adverse drug reactions (ADRs)” including: “serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), elevated ammonia and bi...